The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Frederick, United States
1-10 Employees
We are the leader in surface design through microfabrication techniques for in vitro platforms and functionalizing biosensors. Our products are designed to address a specific gap in technology to open new avenues of exploration and analysis resulting in novel assay development and unlocking unprecedented insights while accelerating the data acquisition process and enhancing reproducibility. Nanocrine surface chemistry biochips support cell viability in the absence of FBS. Devote time to what truly matters and minimize time wasted on sample preparation with products that are ready to use. Cell culturing platforms, the surfaces that interface with cells and provide physical and chemical input, have been disproportionately neglected. Reduce the time it takes to reveal morphological biomarkers associated with epithelial-mesenchymal-transition on Nanocrine Surface Chemistry Biochips.
+
Featured
cRGD Surface Chemistry Biochip Starter Kit (Cat. #N9-RGSK)
... The cRGD Surface Chemistry Biochip Starter Kit provides all the essential components needed to rapidly assess cells in your research. ...
Cambridge, United Kingdom
11-50 Employees
2010
We are passionate about creating innovative solutions and are looking for talented individuals to join us in shaping the future of technology. Sphere Fluidics’ platforms are built on over a decade of scientific and engineering research and development. Originally spun out from the University of Cambridge, we specialize in multiple technical areas to deliver miniaturization. This provides an ultra-miniaturized test tube, containing media, reagents, and cells, that allows large-scale experiments at the single cell level. At Sphere Fluidics, we’re committed to delivering high-quality products & services. We believe in continuous learning and improvement and hold ourselves accountable for maintaining integrity at all times. Receive latest updates from Sphere Fluidics about new products, special offers and events. Built upon our picodroplet microfluidic technology, our solutions fit seamlessly into your lab workflow — saving time and providing absolute assurance of quality and reliability.
+
Featured
Droplet Microfluidic Biochips
... Unlock the potential of microfluidic biochips with our expertly developed, platform-agnostic solutions for seamless integration. We also design custom ...
Norderstedt, Germany
11-50 Employees
2005
Our products range from single dispenser systems up to sophisticated Autodrop Platforms (including glove box and production systems). We provide our customers with a number of services like training, dispensing tests, prototyping and customized solutions. Our products are found in several production processes, e. We are specialized in tailor-made solutions in close collaboration with our customer. We focus on high quality products and services for industrial applications as well as for R&D purposes. Provider: YouTube, LLC, 901 Cherry Ave., San Bruno, CA 94066, USA. We offer a number of lab and engineering services to find the best solution for the application demands of our customers. From 3D bioprinting to microarray analysis, we provide in-depth insights and expert resources tailored exclusively for the Life Science community.
+
Featured
micro-dispensing and inkjet printing applications - microdrop Technologies GmbH
... @ BIOCHIP Berlin ...
Hamburg, Germany
1-10 Employees
2018
Aicone has expertise in different business lines, such as Advanced Analytics and Innovation Management.Our Offices are in Hamburg | Mumbai | Bangkok | Kuala Lumpur | Manila. Aicone Biochip is a multi-antigen, multi-domain, fully quantitative serology COVID-19 test. These results will provide critical insights on whether individuals have high titres of potentially neutralising antibodies against SARS-CoV-2 that may protect against reinfection or whether booster vaccinations are required. Until recently there was no COVID-19 antibody test available to provide a quantitative result. Aicone Biochip is a lab-based biochip test that utilises protein folding technology ensuring that viral antigens are correctly folded, preserving all conformational and linear antibody binding sites. Aicone Biochip provides a more accurate determination of sero-prevalence by targeting over 10 different domains of SARS-CoV-2 proteins. There is a wide variation in antibody titres across SARS-CoV-2 infected individuals2. There is a high degree of variation in patient-specific antibody responses to the different domains of SARS-CoV-2 proteins3.
+
Featured
Aicone Biochip
... COV2.CO | EN | Aicone Biochip - Fully quantitative serology COVID-19 ...
Munich, Germany
11-50 Employees
2017
Wir entwickeln Anwendungen, die neuartige Auswertungen erlauben oder bestehende Mess-Parameter kostengünstiger und in kleineren Bauräumen erheben können. BioChip Systems ist ein forschungsstarker Anbieter von bioelektronischen Applikationen. Wir glauben an das zukünftige Zusammenwachsen von Biologie und Mikroelektronik.
+
Featured
Sensorik | Bayern | BioChip Systems
... BioChip Systems ist ein forschungsstarker Anbieter von bioelektronischen Applikationen. ...
York, United States
11-50 Employees
1948
Mission: CTI works to fulfill its vision by being compliant with FDA 21 CFR Part 820 and certification to ISO 13485:2016 ensuring CTI’s ability to take a medical device project from conception to FDA clearance and completion. History: Started in 1970, Conductive Technologies Inc., (CTI) is a leading global developer and manufacturer of printed electronics used to create electrochemical sensors, biosensors, flexible circuits, and membrane switches.
+
Featured
Biochips / Microfluidics
... Biochips Biochips offer miniaturized Multiplexed Point of Care Test (MPOCT) capabilities. These chips reside on silicon or other solid substrates that permit numerous tests to be performed at the same time. Typically biochip circuits are produced using photolithography which is a slow ...
City of Edinburgh, United Kingdom
11-50 Employees
2000
Arrayjet is a leading microarray company that provides solutions to researchers and development groups across academia, biotechnology, pharma and diagnostics. Arrayjet Ltd was established in 2000 with private equity from Archangel Investors Ltd and the Scottish Government. Arrayjet is at the global forefront of this field and has installed instruments throughout 5 continents since commercialisation in 2006. In 2011 Arrayjet Advance™ was launched to offer contract research and contract manufacturing services. In 2021 we launched operations in the USA with the formation of Arrayjet Inc. The help us assess whether our services and products are reaching our intended audience in an effective way we make use of marketing platforms such as Google Ads and LinkedIn.
+
Featured
Flexible microarray, biochip and microfluidic solutions.
... Flexible microarray, biochip and microfluidic solutions. ...
Dresden, Germany
11-50 Employees
2011
Die enge Zusammenarbeit mit namenhaften Kunden weltweit zeugt vom großen Vertrauen in unsere Dienstleistungen. Richard Gloaguen wurde beim Wettbewerb um den Sächsischen Staatspreis für Transfer 2023 mit dem 2. Ausgezeichnet wurde das Ausgründungsvorhaben TheiaX, das nachhaltige, effiziente Rohstofferkundung mit KI-gestützten Bildgebungs- & Kartierungsverfahren am Markt anbietet. Zusätzlich bieten wir ergänzende Produkte wie die Nadelsonde zur Messung des lokalen Gasgehalts, das Prozessmikroskop zur Analyse von Partikeln und Zellen sowie die Clock-Box zur synchronen Triggerung verschiedener Messsysteme.
+
Featured
Impedanz-Biochip - HZDR Innovation
... Mit dem Impedanz-Biochip PolCarr® lässt sich die Anzahl biologischer Spezies wie Bakterien in Flüssigkeit schnell, ohne zu Verdünnen und optik-frei bestimmen. ...
Winterthur, Switzerland
2015
Discuss your visions with us on an equal footing and allow us to inject our enthusiasm into your project. We produce pilot runs or prototypes on the series machines, meaning that you get attractive, clean and valuable products that are nothing short of perfect. Offering innovation, individual support with optimising ideas and expertise on feasibility, we facilitate quick and flexible processes. Creation and conception lead to the perfect product. Our varied production methods allow for processes to be adjusted to the relevant series runs at any time, whilst maintaining the same high quality and without extending the process. You will be able to plan reliably because we stick to deadlines and handle products with care right through to delivery. A high level of automation guarantees the necessary production reliability and security, and ensures that production is environmentally friendly.
+
Featured
Highly functional: microfluidic biochips for the biotechnology of the future
... Highly functional: microfluidic biochips for the biotechnology of the ...
Santa Barbara, United States
101-250 Employees
2000
Atomica offers the most complete wafer fabrication services, featuring the largest pure-play MEMS production fab and most extensive suite of tools of any independent manufacturer. Beyond the standard offering, Atomica has a proven track record of bringing it all together. Read about Atomica’s MEMS design and modeling services that complement our wafer foundry capabilities. Learn about Atomica’s photolithography technologies and leading-edge greyscale (3D) lithography. Discover Atomica’s deposition tools and its wide range of metals and dielectric deposition capabilities. Atomica offers both dry etching (RIE, DRIE, ion milling) and wet etching capabilities. Learn how Atomica’s bonding allows hermetic and vacuum wafer-level packaging. Read how Atomica’s Wafer Level Packaging routinely achieves over 99% hermeticity.
+
Featured
Unleashing the power of MEMS | Atomica: MEMS, Photonics, Biochips
... Unleashing the power of MEMS | Atomica: MEMS, Photonics, Biochips ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Biochip
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 34 |
| Amount of suitable service providers | 26 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1948 |
| Youngest suiting company | 2018 |
A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed simultaneously to achieve higher throughput and speed. Typically, a biochip's surface area is no larger than a fingernail. Like a computer chip that can perform millions of mathematical operations in one second, a biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds. The integration of biochips has revolutionized various fields of study and industries, notably in biotechnology and healthcare. Biochips are pivotal in advancing drug discovery, diagnostics, and personal medicine by allowing for the analysis of complex biochemical reactions quickly and accurately. They enable the detection of diseases at an earlier stage, significantly improving patient outcomes. Additionally, in forensic analysis, biochips play a crucial role in genetic fingerprinting and criminology. The versatility and efficiency of biochips mark a significant leap forward in biological sciences, offering a platform for researchers to conduct experiments at a scale and speed that was once deemed unfeasible. Their role in rapidly identifying and managing a wide array of health conditions and diseases underscores their impact, highlighting their importance as a tool for innovation and advancement within their respective field.
1. Enhanced Precision and Accuracy
Biochips provide exceptional precision and accuracy in data analysis, which is paramount in medical diagnostics and research. Their ability to process vast amounts of biological data simultaneously allows for more reliable and exact results compared to traditional methods.
2. Speed and Efficiency
The speed at which biochips can analyze and process data significantly surpasses that of alternative options. This rapid turnaround is crucial in time-sensitive situations, such as disease diagnosis and genetic analysis, facilitating quicker decision-making and treatment initiation.
3. Miniaturization and Portability
One of the standout benefits of biochips is their compact size. This miniaturization not only reduces the need for large laboratory spaces but also paves the way for portable diagnostic tools. Such portability is especially beneficial in remote or resource-limited settings, where traditional laboratory facilities are inaccessible.
4. Cost-Effectiveness
Despite the advanced technology behind biochips, they are becoming increasingly cost-effective. The reduction in size and the ability to conduct multiple analyses simultaneously decrease both the material and operational costs, making high-throughput screening and personalized medicine more accessible.
While evaluating the different suppliers make sure to check the following criteria:
1. Technology Compatibility
Ensure the biochip technology is compatible with existing systems and protocols in your lab or facility, avoiding integration issues.
2. Quality Assurance and Standards
Verify the supplier's adherence to international quality standards, such as ISO certifications, to ensure product reliability and consistency.
3. Customization Capabilities
Assess the supplier's ability to customize biochips according to specific research needs or project requirements, including design and functionality adjustments.
4. Scalability
Consider the supplier's capacity to scale production up or down based on your project's volume requirements, ensuring timely delivery.
5. Technical Support
Evaluate the level of technical support offered, including post-purchase assistance and troubleshooting, to minimize downtime and accelerate research progress.
6. Cost-Effectiveness
Compare pricing among suppliers, but also consider the total value offered, including product quality, customization options, and support services, to ensure a cost-effective partnership.
7. Reputation and Reviews
Research the supplier's reputation within the industry, including customer reviews and testimonials, to gauge reliability and customer satisfaction.
Biochips have revolutionized the healthcare industry by offering rapid and accurate diagnostic solutions. By integrating miniaturized test sites onto a single chip, they enable simultaneous testing for multiple conditions, drastically reducing the time and resources required for diagnostics. This capability is invaluable for hospitals and medical laboratories, facilitating early disease detection and personalized medicine approaches. In the pharmaceutical sector, biochips play a crucial role in drug discovery and development. They allow for high-throughput screening of potential drug candidates against various targets, speeding up the process of identifying promising compounds. This efficiency not only accelerates the pace of drug development but also significantly reduces associated costs, making it a game-changer for pharmaceutical companies. Agriculture is another field where biochips are making a significant impact. They are used in genetic engineering and for monitoring the health and traits of crops and livestock. Through DNA microarrays, biochips can analyze genetic information quickly, helping in the selection of desirable traits for breeding purposes. This technology supports the development of high-yield, disease-resistant crops and healthier livestock, promoting sustainable farming practices. Environmental monitoring benefits from biochips through the detection of pathogens and pollutants in air, water, and soil. Their sensitivity and specificity enable precise and timely detection, aiding in the prevention of environmental degradation and the protection of public health. This application is particularly beneficial for companies specializing in environmental consultancy and remediation services, offering them a powerful tool for assessing and addressing ecological challenges.
Biochips, as of the current technological landscape, predominantly fall within the Technology Readiness Level (TRL) range of 4 to 6, indicating that they have moved beyond theoretical research to validated technologies in a laboratory environment and are approaching the stages of demonstration in relevant environments. This positioning is primarily due to significant advancements in microfabrication and biotechnology, allowing for intricate biological elements to be integrated onto a miniature platform with precision. However, they have not fully reached higher TRLs, such as 7 or 8, where full-scale commercial deployment is achieved, mainly because of challenges related to scalability, reliability under various operational conditions, and integration into existing systems. These technical hurdles include ensuring biochip stability and functionality over time, optimizing the interface between biological components and electronic systems for signal processing, and addressing concerns related to data privacy and security in biochip applications. Furthermore, regulatory approvals present another layer of complexity, as biochips intended for medical diagnostics or environmental monitoring must undergo rigorous validation trials to prove their efficacy and safety. Consequently, while biochips demonstrate promising potential and have achieved significant milestones in laboratory settings, their journey toward widespread commercialization and higher TRLs is contingent upon overcoming these technical and regulatory barriers.
In the Short-Term, advancements in biochip technology are expected to focus on enhancing sensitivity and specificity, enabling the detection of a broader range of biomarkers at lower concentrations. This will likely involve integrating nanomaterials and microfluidics, leading to more portable and cost-effective diagnostic devices. Immediate applications will see biochips playing a crucial role in personalized medicine, allowing for rapid, on-site health diagnostics. The Mid-Term phase is anticipated to witness significant progress in biochip interfacing and data analytics capabilities. As biochips become more sophisticated, their ability to interface seamlessly with digital devices will improve, enabling real-time health monitoring and data analysis. This period will also see the development of biochips capable of multi-analyte detection, which will revolutionize disease diagnosis and monitoring by providing comprehensive health snapshots. In the Long-Term, biochip technology is expected to evolve towards fully integrated systems for health management, incorporating artificial intelligence to predict potential health issues before they manifest. Biochips may become a standard component of a proactive health system, embedded within the human body to monitor and even correct anomalies at the molecular level. This phase will likely extend beyond healthcare, with biochips finding applications in environmental monitoring, agriculture, and biotechnology, fundamentally changing our interaction with biological data.
